GEN ranks not only the top 10 publicly traded developed of editing-based therapies, but the top five privately held companies ...

Chrysalis partners with life science clients, from early-stage biofirms to pharmaceutical firms, CROs, and other life science ...

A Roots Analysis study showed the market for ADC manufacturing is $1.79 billion today, but is expected to grow to $7 billion ...

Nanoneedle tech could enable disease monitoring in real time, allowing clinicians to take multiple, repeatable tests from the ...

PepGen leverages a graph-based approach to improve the detection of hidden protein variants in a computationally efficient manner.

Novel T cell measurement system by Novoviah Pharmaceuticals demonstrates clinical disease detection and monitoring of celiac disease.

Sarepta halts Elevidys shipments for non-ambulatory DMD patients after a second patient death in three months post gene ...

Koby Baranes, PhD, head of science at Clock Bio, cautions, “Aging is not yet fully understood and existing models often fail ...

While commercial uptake by patients still lags and a recent court decision rekindles a legal battle, clinical successes continue.

Massively Parallel Ribosome Profiling (MPRP) enables rapid identification of viral proteins without the need to grow live ...

Recent collaborations highlight a growing interest in building a multiomics-based understanding of health and disease.

BaseData aims to improve AI models in biology by offering a 10-fold expansion of protein diversity compared to all public ...